Getinge AB

GOTHENBERG, V7 · Medtech · Public

Medical devices and hospital equipment for acute care, including surgical systems, sterilization equipment, and intensive care solutions

Claim this profile

Follows are private to you and power your alerts

Updated · getinge.com

Sector
Medtech
Headquarters
GOTHENBERG, V7
Latest Form D
$539M, Oct 2017
Total capital
$539M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$539M
1 Form D · last Oct 2017
108 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

2017FEDERAL ↑EQUITY ↓Cumulative $539M1st Form D$539M
2017FEDERAL ↑EQUITY ↓Cumulative $539M1st Form D$539M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$539M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Ake LarssonDirectorNamed in SEC Form D filings
  • Barbro FridenDirectorNamed in SEC Form D filings
  • Carl BennetDirectorNamed in SEC Form D filings
  • Carsten Grehagen BleckerExecutive OfficerNamed in SEC Form D filings
  • Cecilia Daun WennborgDirectorNamed in SEC Form D filings
  • Dan FrohmDirectorNamed in SEC Form D filings
Show all 22 people
  • Frederic Grehagen PetteExecutive OfficerNamed in SEC Form D filings
  • Jeanette Heden CarlssonExecutive OfficerNamed in SEC Form D filings
  • Jens Grehagen ViebkeExecutive OfficerNamed in SEC Form D filings
  • Joacim Grehagen LindoffExecutive OfficerNamed in SEC Form D filings
  • Johan ByggeDirectorNamed in SEC Form D filings
  • Johan MamlquistDirectorNamed in SEC Form D filings
  • Johan SternDirectorNamed in SEC Form D filings
  • Lena Grehagen HagmanExecutive OfficerNamed in SEC Form D filings
  • Magnus Heden LundbackExecutive OfficerNamed in SEC Form D filings
  • Malin PerssonDirectorNamed in SEC Form D filings
  • Maria Grehagen HedbergDirectorNamed in SEC Form D filings
  • Mattias PerjosExecutive Officer, DirectorNamed in SEC Form D filings
  • Niclas Grehagen SjoswardExecutive OfficerNamed in SEC Form D filings
  • Peter JormalmDirectorNamed in SEC Form D filings
  • Rickard KarlssonDirectorNamed in SEC Form D filings
  • Sofia HasselbergDirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .